Preprint Review Version 1 This version is not peer-reviewed

COVID-19: Considerations for Children and Adolescents with Diabetes

Version 1 : Received: 12 April 2020 / Approved: 14 April 2020 / Online: 14 April 2020 (15:21:52 CEST)
Version 2 : Received: 14 May 2020 / Approved: 15 May 2020 / Online: 15 May 2020 (04:54:43 CEST)

How to cite: Dayal, D. COVID-19: Considerations for Children and Adolescents with Diabetes. Preprints 2020, 2020040225 (doi: 10.20944/preprints202004.0225.v1). Dayal, D. COVID-19: Considerations for Children and Adolescents with Diabetes. Preprints 2020, 2020040225 (doi: 10.20944/preprints202004.0225.v1).

Abstract

Recent reports suggest that the clinical course of coronavirus disease 2019 (COVID-19) in previously healthy children is usually milder as compared to adults. However, children with co-morbid conditions such as diabetes are at increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as morbidity and mortality due to COVID-19. Experience in adults with diabetes shows that they are prone to faster metabolic decompensation, develop diabetes-related complications and have a poor prognosis when hospitalised with COVID-19. The data in children is limited. The aim of this mini-review is to discuss the possible risks to children and adolescents with diabetes during the current pandemic and the special considerations in management in those affected with COVID-19.

Subject Areas

Coronavirus disease 2019; COVID-19; children; diabetes; type 1 diabetes; type 2 diabetes; recommendations

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.